Clinical significance and potential application of cuproptosis-related genes in gastric cancer

Table 1 Univariate and multivariate analysis of the correlation of differentially expressed cuproptosis-related gene expression with overall survival among gastric cancer patients

Gene	Total, n	Univariate analysis		Multivariate analysis
		Hazard ratio (95%CI)	P value	Hazard ratio (95%CI)	P value
ATP7A	370	1.037 (0.725-1.483)	0.842
ATP7B	370	0.922 (0.781-1.088)	0.334
CDKN2A	370	0.985 (0.887-1.094)	0.782
DLAT	370	0.785 (0.577-1.069)	0.124
DLD	370	0.961 (0.678-1.363)	0.825
FDX1	370	0.737 (0.533-1.018)	0.064	0.735 (0.534-1.011)	0.059
GCSH	370	1.054 (0.769-1.446)	0.744
GLS	370	1.052 (0.845-1.310)	0.650
LIAS	370	0.730 (0.498-1.068)	0.105
LIPT1	370	1.168 (0.713-1.916)	0.537
LIPT2	370	1.014 (0.794-1.294)	0.912
MTF1	370	0.642 (0.410-1.006)	0.053	0.661 (0.411-1.064)	0.088
NFE2L2	370	0.701 (0.477-1.031)	0.071	0.809 (0.534-1.225)	0.317
NLRP3	370	1.279 (0.946-1.729)	0.110
PDHA1	370	0.873 (0.632-1.206)	0.409
PDHB	370	1.051 (0.686-1.611)	0.818
SLC31A1	370	0.834 (0.653-1.065)	0.146

CI: Confidence interval.